TY  - JOUR

T1  - Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis

JO  - Clinical and Experimental Dermatology

UR  - http://dx.doi.org/10.1093/ced/llad129

PY  - 2023/04/10

AU  - Bieber T

AU  - Thyssen JP

AU  - Irvine AD

AU  - Tsunemi Y

AU  - Chen Y-F

AU  - Sun L

AU  - Schloebe A

AU  - Riedl E

AU  - Cork MJ

ED  - 

DO  - DOI: 10.1093/ced/llad129

PB  - Oxford University Press (OUP)

VL  - 48

IS  - 8

SP  - 881

EP  - 888

Y2  - 2024/12/22

ER  -